Circulating Tumor DNA (ctDNA) in Breast Cancer: 2023 COEDS Ft Lauderdale Conference
Dr Naomi Dempsey, MD from Miami Cancer Institute comments on the use of circulating tumor DNA (ctDNA) methodologies in breast cancer: Liquid biopsy to detect actionable molecular alterations in the metastatic setting, and a more investigational use in primary breast cancer to monitor for minimal residual disease.
Related Resources